This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Suh G-H, Jung HY, Lee CU, Choi S, Korean Galantamine Study Group.Economic and clinical benefits of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population: a 52-week prospective study. Journal of the Korean Medical Association 23: 10-17, No. 1, Feb 2008
Rights and permissions
About this article
Cite this article
Galantamine has a head for costs in AD. Pharmacoecon. Outcomes News 550, 3 (2008). https://doi.org/10.2165/00151234-200805500-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805500-00005